Author/Authors :
Modarres Gilani Mitra نويسنده , Nasiri Setare نويسنده Department Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran , Mousavi Azamosadat نويسنده Department Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran , Sheikh Hasani Shahrzad نويسنده Department Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran , Rahim Vakili Mohammad نويسنده Department Thorax surgery, Tehran University of Medical Sciences, Tehran, Iran , Akhavan Setare نويسنده Department Gynecology Oncology, Iran University of Medical Sciences, Tehran, Iran , Mirzaei Monire نويسنده Department Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Introduction
The incidence of vulvar cancer is nearly 5% of all gynecologic malignancies and almost 95% of vulvar cancers are squamous cell carcinoma (SCC). Recurrence is possible in 4 ways: local, regional, pelvic, and distant. In a cohort of 391 patients with vulvar SCC, distant metastasis was reported 5% .The common sites of distant metastasis are pelvic nodes, lung, and liver. Both skin and bone metastasis are rare in vulvar SCC.
Case Presentation
The current report presented a 58-year-old female with the diagnosis of vulvar SCC. She was the 11th cutaneous metastasis, 13th bone metastasis, and the 1st case with simultaneous bone and skin metastasis reported in the last 60 years.
Conclusions
It is necessary to consider any lesion on the vulve, especially in menopause females, and it should be the low threshold for biopsy to avoid delay in detection. After completion of selective treatment, the exact follow-up should be considered to discover metastases.
